The medical director of clinical development at AskBio discussed setbacks in the phase 1 trial of AB-1002 gene therapy.
Luke Roberts, MBBS, PhD
Advertisement
Articles by Luke Roberts, MBBS, PhD
The medical director of clinical development at AskBio discussed the progress of an early clinical trial of AB-1002.
The medical director of clinical development at AskBio discussed safety and efficacy data from a phase 1 trial of AB-1002.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CGTlive®
1
CARsgen’s CAR-T Satri-Cel Significantly Reduces CA19-9 Levels in Patients With Pancreatic Ductal Adenocarcinoma
2
Around the Helix: Cell and Gene Therapy Company Updates – October 22, 2025
3
AskBio’s Heart Failure Gene Therapy AB-1002 Shows Ability to Improve NYHA Class in Phase 1 Trial
4
